12th International Pharmaceutical and Medical Device Compliance Congress
The 2018 Co-Chairs led the design of the
Hotel Savoyen, Vienna, AustriaMonday, May 14, 20189:00 am
**PRECONFERENCE II: Patient Support Programs: Risk and Risk Management Best Practices
**This is a deep dive workshop focusing on specific risks related to interacting with Patients and Patient Organizations through Patient Support Programme activities:
Definitions matter – what are we talking about? What are our business colleagues talking about? Is it the same?
What are the most common manifestations or structures of Patient Support Programmes?
What are the risks associated with these common activities? How do these risks “show up” – especially in relation to other activities?
What are best practices for governance and approvals of these activities?
How do you monitor these activities?
- Gary F. Giampetruzzi, JD, Partner, Paul Hastings;Former Vice President and Assistant General Counsel, Head, Government Investigations, Pfizer Inc., New York, NY, USA
Nicolas Honhon, Head, Ethics & Compliance EMEA, UCB Pharma, Vice-Chair, Ethics & Compliance Committee, EFPIA, Brussels, Belgium
Casey J. Horton, CFE Director, Healthcare and Life Sciences Disputes, Regulatory, Compliance and Investigations, Navigant Consulting, Chicago, IL, USA
Laurence Labey, MD Ethics and Business Integrity Business Partner for R&D and Chief Medical Officer, Sanofi, Paris, France
Ann Beasley, JD Director, Navigant Consulting; Former Senior Vice President, Chief Compliance Officer, Biogen; Former Co-chair, International Pharmaceutical and Medical Device Compliance Congress, Boston, MA, USA (Moderator)
For more information, visit the conference